Stock Screener
Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors
Default risk
1
2
3
4
5
6
7
Volatility
1
2
3
4
5
6
7
Stress test
1
2
3
4
5
6
7
Selling difficulty
1
2
3
4
5
6
7
Country risks
1
2
3
4
5
6
7
Other risks
1
2
3
4
5
6
7
Profitability factors
Valuation
1
2
3
4
5
6
7
Analyst view
1
2
3
4
5
6
7
Performance
1
2
3
4
5
6
7
Profitability
1
2
3
4
5
6
7
Growth
1
2
3
4
5
6
7
Dividends
1
2
3
4
5
6
7
Results: 12
Grifols, S.A.
GRF.MCLaboratorios Farmaceuticos Rovi, S.A.
ROVI.MCPharma Mar, S.A.
PHM.MCAlmirall, S.A.
ALM.MCFaes Farma, S.A.
FAE.MCClinica Baviera, S.A.
CBAV.MCAtrys Health, S.A.
ATRY.MCBiotechnology Assets, S.A.
BST.MCLaboratorio Reig Jofre, S.A.
RJF.MCPangaea Oncology, S.A.
PANG.MCPrim, S.A.
PRM.MCOryzon Genomics S.A.
0RDB.L
Return for Q2 2026:-7.51%
Portfolio composition:
Return for Q2 2026:10.41%
Portfolio composition: